STOCK TITAN

GoodRx Holdings, Inc. - GDRX STOCK NEWS

Welcome to our dedicated page for GoodRx Holdings news (Ticker: GDRX), a resource for investors and traders seeking the latest updates and insights on GoodRx Holdings stock.

GoodRx Holdings, Inc. (Symbol: GDRX) is a leading consumer-focused digital healthcare platform committed to reducing the cost of healthcare in the United States. The company operates a price comparison platform that provides consumers with current, geographically relevant pricing for prescription medications. GoodRx gathers prices from multiple sources, offering powerful savings tips, valuable discounts, and negotiable price codes for prescriptions at virtually every pharmacy across the US.

GoodRx serves millions of Americans each month, including thousands of physicians who use the platform to help their patients. To date, the company has saved users over $3 billion on their prescription drug costs. Despite this success, GoodRx continues to work toward making prescriptions affordable for all Americans.

The company's core revenue stream comes from pharmacy benefit managers (PBMs), who manage formularies and prescription transactions. GoodRx also offers additional healthcare products and services such as pharma manufacturer solutions, subscription plans, and telehealth services. Their platform extends beyond individual consumers to include solutions for health plans, payors, and PBMs through an easy-to-use website and mobile app experience known as GoodRx for Benefits.

As GoodRx continues to innovate and expand its offerings, it remains dedicated to its mission of lowering healthcare costs and making essential medications accessible to everyone in the US. Stay updated with the latest news and developments from GoodRx to see how they are transforming the healthcare landscape.

Rhea-AI Summary

TherapeuticsMD (NASDAQ: TXMD) has successfully completed the $150 million divestiture of vitaCare Prescription Services to GoodRx (NASDAQ: GDRX). This strategic move, initially announced on March 6, 2022, allows TXMD to concentrate on its women's health portfolio. The company could also receive an additional $7 million based on vitaCare's 2023 financial performance. CEO Hugh O’Dowd emphasized the importance of this transaction in enhancing value for shareholders and patients.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.88%
Tags
none
-
Rhea-AI Summary

GoodRx (GDRX) has completed its acquisition of vitaCare for $150 million in cash, plus an additional $7 million contingent on vitaCare's financial performance. This acquisition enhances GoodRx's capabilities in assisting pharmaceutical manufacturers and improving patient access to affordable medications. The deal is expected to strengthen GoodRx's Pharma Manufacturer Solutions, improving patient adherence to prescribed therapies. The company plans to address the financial impact of this acquisition during its upcoming earnings call on May 9, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.88%
Tags
-
Rhea-AI Summary

GoodRx Holdings Inc. (GDRX) is set to release its Q1 2022 financial results after U.S. markets close on May 9, 2022. Management will hold a conference call at 2:00 p.m. PT to discuss the results and the company’s outlook. Interested parties can access the information via their investor relations website. GoodRx has saved consumers over $35 billion since its inception, solidifying its position as a leading digital healthcare platform.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.89%
Tags
Rhea-AI Summary

TherapeuticsMD has agreed to divest its vitaCare Prescription Services business to GoodRx for $150 million in cash, plus up to $7 million contingent on vitaCare's 2023 performance. The deal is set to close in Q2 2022, allowing TXMD to focus on its core women's health business. CEO Hugh O’Dowd expressed confidence in GoodRx's ability to enhance patient access. TXMD will discuss this transaction in its earnings call on March 10, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.95%
Tags
none
-
Rhea-AI Summary

GoodRx (NASDAQ: GDRX) has announced an agreement to acquire vitaCare Prescription Services from TherapeuticsMD for $150 million, plus up to $7 million contingent on performance through 2023. The acquisition aims to enhance patient access and adherence to brand medications by addressing affordability and insurance communication barriers. GoodRx expects this transaction to contribute under 1% to overall revenue and reduce adjusted EBITDA margin by about 2% in 2022, while anticipates future growth in revenue and profitability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.95%
Tags
-
Rhea-AI Summary

GoodRx Holdings has released its fourth quarter and full year 2021 financial results, highlighting its role as a leading digital healthcare platform. The company has saved consumers over $35 billion since its inception in 2011. A conference call to discuss these results is scheduled for today at 2:00 p.m. PT. Investors can access the live call and its archive on the GoodRx investor relations website.

GoodRx continues to grow as one of the most downloaded medical apps.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-38.91%
Tags
Rhea-AI Summary

GoodRx Holdings has announced a new share repurchase program authorized to buy back up to $250 million of its Class A Common Stock. The program aims to enhance shareholder value and reflects the company's confidence in its future growth. Repurchases will be executed based on market conditions, using existing cash and cash equivalents, with reports indicating $941.1 million in cash available as of December 31, 2021. The program is effective immediately and may be modified or terminated by the Board at their discretion before February 23, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-38.91%
Tags
buyback
-
Rhea-AI Summary

GoodRx Holdings Inc. (NASDAQ: GDRX) announced its participation in key investor conferences in March. Executives will present at the Raymond James 43rd Annual Institutional Investors Conference in Orlando, FL, on March 8 at 7:25 a.m. PT; at the Cowen 42nd Annual Health Care Conference virtually on March 9 at 8:10 a.m. PT; and at the Deutsche Bank 30th Annual Media, Internet & Telecom Conference in Palm Beach, FL, on March 15 at 6:35 a.m. PT. Live webcasts and archived recordings will be accessible via their Investor Relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.99%
Tags
conferences
-
Rhea-AI Summary

GoodRx Holdings Inc. (NASDAQ: GDRX) will release its fourth quarter and full year 2021 financial results after U.S. markets close on February 28, 2022. A conference call will occur at 2:00 p.m. PT to discuss the results and future outlook. The financial results will be available on their investor relations website. GoodRx, a leading digital healthcare platform, has helped consumers save over $35 billion since 2011, establishing itself as a crucial resource for affordable healthcare.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.16%
Tags
Rhea-AI Summary

GoodRx Holdings, Inc. (Nasdaq: GDRX) will present at the virtual 40th Annual J.P. Morgan Healthcare Conference on Thursday, January 13, at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time). A live webcast of the presentation will be accessible via the Company’s Investor Relations website, and an archived recording will be available for at least 30 days post-conference. Since its inception in 2011, GoodRx has helped Americans save over $35 billion, making healthcare more affordable and convenient.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.49%
Tags
conferences

FAQ

What is the current stock price of GoodRx Holdings (GDRX)?

The current stock price of GoodRx Holdings (GDRX) is $4.49 as of December 24, 2024.

What is the market cap of GoodRx Holdings (GDRX)?

The market cap of GoodRx Holdings (GDRX) is approximately 1.7B.

What does GoodRx Holdings, Inc. do?

GoodRx Holdings, Inc. is a digital healthcare platform that helps reduce the cost of prescriptions by offering price comparisons, discounts, and savings tips for medications across the US.

How does GoodRx save money on prescriptions?

GoodRx collects and compares current prescription prices from various sources, providing users with discounts and negotiable price codes that can be used at nearly every pharmacy in the US.

Who benefits from using GoodRx?

Millions of Americans, including those with insurance or Medicare, benefit from using GoodRx to find affordable prescription prices. Physicians also use GoodRx to help their patients save money.

How much has GoodRx saved Americans so far?

GoodRx has saved Americans over $3 billion on their prescription drug costs.

What additional services does GoodRx offer?

Besides price comparison and discounts, GoodRx offers pharma manufacturer solutions, subscription plans, telehealth services, and GoodRx for Benefits, which provides solutions for health plans, payors, and PBMs.

How does GoodRx generate revenue?

GoodRx generates revenue primarily from pharmacy benefit managers (PBMs) who manage formularies and prescription transactions. The company also earns from its additional healthcare products and services.

What is GoodRx for Benefits?

GoodRx for Benefits is a technology solution that provides health plans, payors, and PBMs with an easy-to-use website and mobile app experience to manage and reduce healthcare costs.

Is GoodRx available as a mobile app?

Yes, GoodRx offers a mobile app that allows users to compare prescription prices, find discounts, and access savings tips on the go.

Why should I use GoodRx if I already have insurance?

Even with insurance or Medicare, prescription costs can be high. GoodRx helps you find lower prices and better discounts, making medications more affordable.

Where can I learn more about GoodRx?

Visit www.goodrx.com to learn more about how GoodRx can help you save on prescriptions and explore their additional healthcare services.

GoodRx Holdings, Inc.

Nasdaq:GDRX

GDRX Rankings

GDRX Stock Data

1.71B
88.22M
11.9%
70.75%
1.96%
Health Information Services
Services-computer Processing & Data Preparation
Link
United States of America
SANTA MONICA